Premium
O4‐04‐04: ABT‐089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors
Author(s) -
Lenz Robert A.,
Garimella Tushar,
Dutta Sandeep,
Locke Charles,
Baker Jeffrey D.,
Wesnes Keith,
Maruff Paul,
AbiSaab Walid M.,
Saltarelli Mario D.
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.543
Subject(s) - tolerability , placebo , medicine , pharmacokinetics , pharmacology , adverse effect , concomitant , clinical trial , acetylcholinesterase inhibitor , crossover study , acetylcholinesterase , anesthesia , pathology , chemistry , biochemistry , enzyme , alternative medicine